# Astaxanthin Market

> Astaxanthin Market Size, Share, Industry Trend & Analysis Research Report Information By Source (Natural, Synthetic, Yeast-Derived, Bacterial/Other), By Application (Aquaculture Feed, Dietary Supplements, Cosmetics & Personal Care, Food & Beverages, Animal Nutrition), By Form (Oleoresin/Oil, Powder/Dried Biomass, Liquid Concentrate, Beadlets/Encapsulated) – Forecast Till 2035

- **Forecast Period:** 2026-2035
- **CAGR:** 7.9%
- **2025:** USD 2.10 Billion
- **2035:** USD 4.18 Billion
- **Key Players:** BASF SE, DSM-Firmenich, Cyanotech Corporation, AstaReal AB (Fuji Chemical), BGG (Beijing Gingko Group), Fenchem Biotek, Algalif Iceland, NHU (Zhejiang NHU)

**Report ID:** MRFR/FnB/3406-CR · **Pages:** 110 · **Author:** Snehal Singh · **Last Updated:** July 01, 2026

**URL:** https://www.marketresearchfuture.com/reports/astaxanthin-market-4833

---

## Market Summary

As per Market Research Future analysis, the Astaxanthin Market Size was estimated at 1.998449191 USD Billion in 2024. The Astaxanthin industry is projected to grow from 2.2 USD Billion in 2025 to 6.1 USD Billion by 2035, exhibiting a compound annual growth rate (CAGR) of 10.7% during the forecast period 2025 - 2035

## Market Drivers

| Driver | ~% Impact on CAGR | Geographic Relevance | Impact Timeline | Ref |
| --- | --- | --- | --- | --- |
| Rising demand for astaxanthin antioxidant supplement products | +1.8% | Global | Short-term (≤2 yr) |   |
| Salmon aquaculture astaxanthin feed expansion | +1.5% | Europe, Asia-Pacific | Medium-term (2–4 yr) | [3] |
| Astaxanthin skin health benefit clinical validation | +1.2% | North America, Europe | Medium-term (2–4 yr) | [9] |
| Shift from synthetic to naturalistic astaxanthin sourcing | +1.0% | Global | Long-term (≥4 yr) | [4] |
| naturalistic astaxanthin microalgae source capacity buildout | +0.9% | Asia-Pacific, North America | Medium-term (2–4 yr) | [5] |
| Functional food regulatory harmonization | +0.7% | Europe, Japan | Long-term (≥4 yr) | [11] |
| Sports nutrition and eye health clinical studies | +0.5% | North America | Short-term (≤2 yr) | [12] |

### Consumer Demand for Antioxidant Supplements

Global spending on antioxidant dietary supplements surpassed USD 8.2 billion in 2024, with astaxanthin positioned as the fastest-penetrating carotenoid in the category . Clinical trials published in the Journal of Clinical Biochemistry and Nutrition demonstrated that 12 mg/day dosing of astaxanthin antioxidant supplement formulations reduced oxidative stress biomarkers by 18–22% over 12 weeks [12]. This evidence base is converting skeptical mainstream retailers — Costco and Walgreens both expanded astaxanthin shelf space in 2024 — and pulling price-insensitive health consumers toward premium natural-source capsules. The Astaxanthin Market benefits directly as supplement-grade product commands 3–5× the price per kilogram of feed-grade material.

### Aquaculture Feed Intensification

Salmon farming output is projected to grow at 4.6% annually through 2030, and astaxanthin is the pigmentation standard that drives consumer willingness to pay for the signature orange-pink flesh color [3]. Norway's salmon aquaculture astaxanthin feed consumption alone exceeded 520 metric tons in 2024, while Chile's post-ISA recovery has restored volumes to pre-2022 levels [13]. The synthetic versus naturalistic astaxanthin debate is intensifying in this vertical as retailers like Whole Foods and Carrefour now label farmed salmon with "naturally pigmented" claims, nudging feed converters toward Haematococcus-derived supply. This feed-level substitution trend adds a structural premium layer to the Astaxanthin Market.

### Skin Health and Cosmeceutical Adoption

Oral astaxanthin has been proven to boost skin health at 4–6 mg/day in peer-reviewed dermatology research, displaying measurable benefits in skin elasticity, moisture retention and UV-induced wrinkle depth [9]. The worldwide cosmeceuticals industry – estimated at more than USD 72 billion in 2024 – is incorporating astaxanthin microalgae source extracts into serums, masks and ingestible cosmetic products. In 2023–2024, L’Oréal’s La Roche-Posay and Shiseido both filed patent applications mentioning astaxanthin delivery systems, indicating that established beauty conglomerates view the substance as a long-cycle development platform, not a trend [14].

### Regulatory Tailwinds for Natural-Source Products

EFSA's 2022 positive opinion on Haematococcus pluvialis-derived astaxanthin as a novel food ingredient at up to 8 mg/day unlocked the EU's 450-million-consumer supplement channel for natural-source producers [11]. Japan's FOSHU and Foods with Function Claims frameworks already list over 30 astaxanthin-containing products. In the United States, multiple self-affirmed GRAS notifications have cleared FDA review since 2021, streamlining commercial launch timelines for the Astaxanthin Market [15].

## Restraints

The restraint impact percentages below follow the same directional methodology described in Section 4. They represent estimated headwinds, not precise drags on the CAGR figure.

| Restraint | ~% Impact on CAGR | Geographic Relevance | Impact Timeline | Ref |
| --- | --- | --- | --- | --- |
| High production cost of astaxanthin microalgae source | –1.2% | Global | Medium-term (2–4 yr) | [4] |
| Price volatility of synthetic versus naturalistic astaxanthin feedstock | –0.8% | Europe, Asia-Pacific | Short-term (≤2 yr) | [16] |
| Limited consumer awareness outside core markets | –0.6% | South America, MEA | Long-term (≥4 yr) | [17] |
| Regulatory fragmentation across jurisdictions | –0.5% | Global | Medium-term (2–4 yr) | [11] |
| Competition from alternative carotenoids (lutein, beta-carotene) | –0.4% | North America | Long-term (≥4 yr) |   |

### Production Cost Barriers

Closed photobioreactor cultivation of Haematococcus pluvialis remains capital-intensive, with production costs ranging from USD 2,500–7,000 per kilogram of pure astaxanthin depending on scale and geography [4]. Synthetic astaxanthin, by contrast, costs roughly USD 1,000–1,500 per kilogram, creating a persistent 2–4× price gap that limits natural-source penetration in price-sensitive salmon aquaculture astaxanthin feed contracts. While heterotrophic fermentation and open-raceway innovations are closing this gap, breakeven at industrial scale is unlikely before 2029–2030, temporarily restraining the Astaxanthin Market growth rate.

### Supply Chain Price Volatility

BASF and DSM-Firmenich together control roughly 60% of synthetic astaxanthin output, and periodic plant shutdowns — such as DSM's Kaiseraugst facility maintenance in Q3 2023 — have triggered spot-price spikes of 20–35% within weeks [16]. These price swings create procurement uncertainty for mid-sized aquaculture operations and dietary supplement brands that lack long-term offtake agreements, discouraging smaller formulators from committing to the Astaxanthin Market.

### Consumer Awareness Gaps

Outside of North America, Japan and Scandinavia, brand awareness of astaxanthin among supplement-aware end customers is still quite low [17]. In expanding areas such as Brazil, India and the Middle East, the substance will face well-established rivals such as lutein and beta-carotene, which have had the benefit of decades of marketing dollars and familiarity with doctors.

## Opportunities

### Precision Fermentation and Next-Generation Production

The development of modern biotechnology platforms represents a prominent long-term frontier for reducing the high operating costs associated with traditional microalgal cultivation. Metabolic engineering of robust yeast hosts, such as Yarrowia lipolytica, along with specialized bacterial expression systems, is actively pursued to biosynthesize high-purity astaxanthin via precision fermentation. Concurrently, microalgae innovation firms are successfully scaling sustainable production systems; for instance, European biotechnology player Microphyt secured a major strategic funding round led by corporate venture vehicles like L’Oréal’s BOLD fund to expand its pipeline of microalgae-derived bioactive ingredients for commercial consumer lines.

### Personalized Nutrition and Direct-to-Consumer Channels

The sustained evolution of the direct-to-consumer (DTC) nutraceutical sector provides a highly effective distribution channel for premium, high-potency functional ingredients. Consumers seeking transparent, science-backed formulations increasingly seek out advanced carotenoid supplements. Within this marketplace, subscription platforms and custom vitamin producers leverage digital profiling tools and algorithmic engines to identify consumer needs. This methodology allows providers to seamlessly incorporate specialized antioxidants into tailored regimens for individuals prioritizing skin rejuvenation, macular health, or exercise-induced athletic recovery, creating a predictable demand flow for high-grade astaxanthin suppliers.

### Emerging-Market Aquaculture Growth

The steady expansion of commercial aquaculture networks across Southeast Asia and Latin America—particularly within intensive shrimp farming operations in countries like Vietnam, Indonesia, and Ecuador—presents an evolving geographic demand corridor for functional aquatic feeds. While tilapia cultivation primarily utilizes standard nutrition profiles, commercial crustacean farming relies heavily on specific dietary carotenoids to optimize immune resilience, health, and natural shell pigmentation. The diversification of aquaculture sectors into these high-value tropical species provides alternative revenue channels for astaxanthin feed manufacturers.

### Pet Nutrition and Animal Health

The continuous premiumization of the companion animal health and nutrition sector is expanding the market for human-grade functional additives. Pet owners are showing an increased willingness to pay for premium nutraceutical profiles, prompting specialty feed formulators to introduce astaxanthin into premium formulations for dogs and cats. This adjacent vertical offers a valuable higher-margin channel for commercial producers, allowing them to diversify their revenue streams beyond traditional human-grade dietary supplements.

## Future Outlook

### Biotechnology-Driven Cost Deflation

CRISPR-edited microalgae strains and continuous-flow photobioreactor designs are expected to significantly reduce astaxanthin microalgae source production costs by significantly by 2030, according to projections from the Algae Biomass Organization [4][19]. As cost parity with synthetic material approaches, the Astaxanthin Market will likely see accelerated substitution in aquaculture feed — the largest volume segment — fundamentally reshaping the synthetic versus naturalistic astaxanthin competitive balance.

### Functional Food Mainstreaming

Astaxanthin is migrating beyond capsules into [fortified beverages](https://www.marketresearchfuture.com/reports/fortified-beverages-market-2960), gummies, and functional snacks. The global functional food sector is expected to have an outstanding market value, and astaxanthin antioxidant supplement delivery in food matrices could expand the addressable Astaxanthin Market. Japan's innovation ecosystem — with brands like DHC and FANCL — will pioneer this shift.

### Sustainability and ESG-Driven Sourcing

Aquaculture certifications (ASC, BAP) are increasingly mandating traceable, low-environmental-impact feed ingredients. Astaxanthin microalgae source produced via carbon-capture-integrated photobioreactors aligns with Scope 3 emission targets for major salmon producers [6][21]. ESG reporting requirements under the EU CSRD and SEC climate disclosure rules will push procurement teams toward verifiable sustainable sourcing, benefiting the Astaxanthin Market's natural segment.

### Clinical Pipeline Expansion

The transition of astaxanthin from a generic dietary supplement to an active investigational product in rigorous clinical trials underscores a broader trend toward evidence-based, marine-derived therapeutics. To successfully navigate clinical progression and secure regulatory approvals, upcoming research initiatives are prioritizing advanced delivery systems to enhance bioavailability, establishing standardized dosage frameworks across varying demographics, and conducting larger, multi-center trials to translate verified preclinical outcomes into reproducible human therapeutic success.[12][22].

## Segment Insights

### By Source

| Segment | Key Metric | Primary Demand Driver |
| --- | --- | --- |
| Natural (Haematococcus pluvialis) | 42% share (2025) | Clean-label consumer preference; regulatory approvals |
| Synthetic | USD 910 M (2025) | Cost advantage in high-volume feed |
| Yeast-Derived (Phaffia rhodozyma) | 9.1% CAGR | Specialty fermentation; non-GMO positioning |
| Bacterial/Other | USD 52 M (2025) | Emerging biotech platforms |

The Astaxanthin Market's source segmentation reflects a fundamental tension between price and purity. Astaxanthin microalgae source from Haematococcus pluvialis dominates the supplement and cosmetics channels, where consumers willingly pay USD 4,000–7,000/kg for verified natural origin and superior esterified forms. Synthetic astaxanthin — primarily manufactured by BASF, DSM-Firmenich, and NHU — remains the workhorse of salmon aquaculture astaxanthin feed, where price sensitivity overrides purity concerns. The synthetic versus naturalistic astaxanthin split is gradually shifting toward natural as production costs decline and retailer sourcing policies tighten.

Yeast-derived astaxanthin from Phaffia rhodozyma occupies a niche but fast-growing position, appealing to formulators who want a fermentation-based, non-GMO alternative to microalgae. This segment's 9.1% CAGR reflects strong interest from European and Japanese supplement brands seeking supply diversification.

### By Application

| Segment | Key Metric | Primary Demand Driver |
| --- | --- | --- |
| Aquaculture Feed | 47% share (2025) | Salmon and shrimp pigmentation requirements |
| Dietary Supplements | 9.2% CAGR | Astaxanthin antioxidant supplement demand |
| Cosmetics & Personal Care | USD 210 M (2025) | Astaxanthin skin health benefit formulations |
| Food & Beverages | 8.4% CAGR | Functional food fortification trend |
| Animal Nutrition | USD 65 M (2025) | Pet supplement market growth |

Aquaculture feed remains the volume backbone of the Astaxanthin Market, consuming over 1,200 metric tons annually. Salmon aquaculture astaxanthin feed applications alone account for approximately 80% of this segment, with shrimp and trout making up the balance. Dietary supplements represent the highest-value growth vector, with per-kilogram pricing 3–5× above feed grade and an expanding consumer base driven by aging demographics and preventive health trends across North America and East Asia.

### By Form

| Segment | Key Metric | Primary Demand Driver |
| --- | --- | --- |
| Oleoresin/Oil | 38% share (2025) | Soft-gel capsule and cosmetic formulations |
| Powder/Dried Biomass | USD 650 M (2025) | Feed premix and tablet manufacturing |
| Liquid Concentrate | 8.7% CAGR | Beverage fortification and topical serums |
| Beadlets/Encapsulated | USD 125 M (2025) | Stability-enhanced delivery for functional foods |

## Regional Market Share Analysis

| Region | Key Metric | Primary Investment Themes |
| --- | --- | --- |
| North America | 36% share (2025) | Supplement retail; clinical research; natural-source preference |
| Europe | USD 588 M (2025) | Salmon aquaculture astaxanthin feed; cosmetics regulation |
| Asia-Pacific | 9.4% CAGR (2026–2035) | Functional foods; shrimp/salmon farming; astaxanthin microalgae source |
| South America | USD 105 M (2025) | Salmon farming in Chile: supplement market entry |
| Middle East & Africa | 7.1% CAGR (2026–2035) | Aquaculture pilot projects; import-dependent supplement demand |
| Total | USD 2.10 B (2025) | — |

The Astaxanthin Market exhibits a clear North America–Europe–Asia-Pacific triad, with emerging regions gaining share as aquaculture and supplement distribution networks mature.

### North America

| Country | Key Metric | Key Driver |
| --- | --- | --- |
| United States | 82% of regional share | Supplement retail dominance; FDA GRAS approvals |
| Canada | USD 72 M (2025) | Salmon farming in British Columbia |
| Mexico | 6.5% CAGR | Growing middle-class supplement adoption |

The United States alone accounts for over USD 620 million in Astaxanthin Market revenue, powered by a supplement industry where astaxanthin antioxidant supplement SKUs grew 28% in tracked retail channels between 2022 and 2024 . Canada's west-coast aquaculture sector consumes significant volumes, while Mexico's expanding pharmacy chains are introducing astaxanthin capsules to health-conscious urban consumers.

### Europe

| Country | Key Metric | Key Driver |
| --- | --- | --- |
| Norway | 31% of regional share | World's largest salmon aquaculture astaxanthin feed consumer |
| Germany | USD 68 M (2025) | Supplement and cosmetics demand |
| United Kingdom | 7.8% CAGR | E-commerce supplement growth |
| France | USD 42 M (2025) | Cosmeceutical innovation; astaxanthin skin health benefit claims |

Europe's Astaxanthin Market is structurally split between industrial feed demand in Scandinavia and Scotland and consumer health demand in Western Europe. EFSA's novel food framework gives the region a regulatory moat that favors established astaxanthin microalgae source suppliers with full dossier approvals [11].

### Asia-Pacific

| Country | Key Metric | Key Driver |
| --- | --- | --- |
| Japan | 34% of the regional share | Functional food culture; FOSHU registrations |
| China | 10.2% CAGR | Haematococcus cultivation buildout; domestic supplement boom |
| India | USD 38 M (2025) | Shrimp aquaculture; emerging supplement market |
| Australia | 7.5% CAGR | Premium supplement consumers: salmon farming in Tasmania |

Asia-Pacific is the engine of the Astaxanthin Market's next growth phase. Japan's Fuji Chemical Industry and China's BGG/Yunnan Alphy are scaling astaxanthin microalgae source production. At the same time, India's shrimp export industry — the world's largest — increasingly requires carotenoid feed additives to meet EU color-quality import standards [3][5].

### South America

| Country | Key Metric | Key Driver |
| --- | --- | --- |
| Chile | 78% of regional share | Second-largest global salmon producer |
| Brazil | 8.1% CAGR | Urban supplement retail expansion |

Chile's salmon aquaculture astaxanthin feed demand anchors South America's position, with annual feed-grade astaxanthin imports exceeding 280 metric tons. Brazil's nutraceutical channel is nascent but growing rapidly as pharmacy chains stock imported astaxanthin antioxidant supplement brands from the United States and Europe.

### Middle East & Africa

| Country | Key Metric | Key Driver |
| --- | --- | --- |
| UAE | 42% of regional share | Premium supplement imports; medical tourism |
| Saudi Arabia | 7.8% CAGR | Vision 2030 aquaculture investments |
| South Africa | USD 12 M (2025) | Health-conscious urban demographic |

The MEA Astaxanthin Market remains import-dependent, but Saudi Arabia's Red Sea aquaculture zones — part of the NEOM development plan — could create localized feed demand by 2030. UAE's mature retail and e-commerce channels already carry premium astaxanthin skin health benefit products from global brands.

## Competitive Benchmarking

The Astaxanthin Market is moderately concentrated, with the top five players holding an estimated 48–55% combined revenue share. The Herfindahl-Hirschman Index (HHI) sits in the 1,200–1,500 range, indicating moderate concentration with a long tail of regional and specialty producers. Competition bifurcates along the synthetic versus naturalistic astaxanthin divide, with synthetic leaders (BASF, DSM-Firmenich) competing on scale and natural producers ([Cyanotech](https://www.cyanotech.com/astaxanthin/), AstaReal) competing on purity and clinical differentiation.

| Company | Est. Revenue Share Range | Key Offerings for the Astaxanthin Market | Strategic Positioning |
| --- | --- | --- | --- |
| BASF SE | ~12–16% | Lucantin® Pink synthetic astaxanthin feed additives | Scale leader in synthetic aquaculture feed |
| DSM-Firmenich | ~10–14% | CAROPHYLL® Pink synthetic astaxanthin | Integrated nutrition & feed ingredients |
| Cyanotech Corporation | ~5–8% | BioAstin® Hawaiian astaxanthin microalgae source | Premium natural-source brand; Kona, Hawaii |
| AstaReal AB (Fuji Chemical) | ~6–9% | AstaReal® astaxanthin capsules and bulk | Clinical-grade astaxanthin; Japan HQ |
| BGG (Beijing Gingko Group) | ~5–7% | AstaZine® astaxanthin from the Yunnan facility | Largest Chinese astaxanthin producer |
| Fenchem Biotek | ~3–5% | Astaxanthin oleoresin and powder | Contract manufacturing; cost-competitive |
| Algalif Iceland | ~2–4% | Astaxanthin from geothermal-powered bioreactors | Sustainable production; EU supply base |
| NHU (Zhejiang NHU) | ~4–6% | Synthetic astaxanthin for feed and supplement | Chinese synthetic scale producer |
| Jingzhou Natural Astaxanthin | ~2–3% | Microalgae-derived astaxanthin bulk | Domestic Chinese market focus |
| Algatech (Solabia Group) | ~2–4% | AstaPure® astaxanthin from the Arava Desert | Premium natural; Israeli innovation cluster |

## Recent News & Developments

- [AstaReal AB](https://www.astareal.se/) (January 2025): Received Japanese FOSHU approval for a new astaxanthin antioxidant supplement targeting cognitive health in adults over 50 [22].
- BGG (November 2024): Commissioned a 120-ton/year Haematococcus pluvialis cultivation plant in Yunnan Province, making it the world's largest single-sit astaxanthin microalgae source facility [5].
- Cyanotech Corporation (September 2024): Partnered with a major U.S. retailer to launch BioAstin® astaxanthin skin health benefit softgels in over 2,000 stores nationwide [14].
- EFSA (June 2024): Published updated safety assessment confirming astaxanthin from Haematococcus pluvialis safe at 8 mg/day for adults, supporting expanded EU supplement marketing [11].
- Algalif Iceland (March 2024): Secured EUR 22 million Series C funding to triple photobioreactor capacity, leveraging Iceland's geothermal energy for carbon-neutral astaxanthin production [19].
- BASF SE (December 2023): Launched a next-generation Lucantin® Pink formulation with improved bioavailability for shrimp feed applications across Southeast Asian markets [3].
- Algatech (Solabia Group) (August 2023): Expanded AstaPure® distribution agreement with a leading European cosmetics group for astaxanthin skin health benefit serums [9].

## Report Scope

| Parameter | Details |
| --- | --- |
| Market Scope | Global Astaxanthin Market covering source, application, form, and regional segmentation. |
| Study Period | 2021–2035 |
| CAGR | 7.9% (2026–2035) |
| Market Size Checkpoints | USD 2.10 B (2025 base); USD 2.27 B (2026); USD 4.18 B (2035) |
| Fastest Growing Segments | Dietary supplements (by application); yeast-derived (by source); Asia-Pacific (by region) |
| Companies Profiled | BASF, DSM-Firmenich, Cyanotech, AstaReal, BGG, Fenchem, Algalif, NHU, Jingzhou Natural, Algatech |
| Valuation Currency | USD (constant 2025 dollars) |

## Frequently Asked Questions

**Q: How does esterified astaxanthin differ from free-form astaxanthin in supplement bioavailability?**
A: Esterified astaxanthin — the dominant form in natural astaxanthin microalgae source extracts — requires enzymatic cleavage in the gut before absorption. Yet, clinical studies show comparable or superior bioavailability versus free-form synthetic astaxanthin when consumed with dietary fat [12]. Most premium supplements use esterified forms because they offer greater oxidative stability during shelf life.

**Q: How does astaxanthin's antioxidant potency compare to other commercial carotenoids?**
A: Astaxanthin demonstrates 6,000 times the singlet-oxygen quenching activity of vitamin C and roughly 550 times that of vitamin E in laboratory assays [12]. This exceptional potency positions the astaxanthin antioxidant supplement category above competing carotenoids like lutein and beta-carotene for oxidative-stress applications.

**Q: What shelf-life considerations affect astaxanthin formulation in functional beverages?**
A: Astaxanthin degrades rapidly under UV light and oxygen exposure, limiting unprotected shelf life to 3–6 months in liquid matrices [20]. Microencapsulation and nitrogen-flushed packaging extend stability to 18–24 months, making beadlet and nanoemulsion delivery systems critical for functional food manufacturers entering the Astaxanthin Market.

**Q: Which emerging aquaculture species beyond salmon are creating new astaxanthin feed demand?**
A: Whiteleg shrimp (Litopenaeus vannamei) and rainbow trout are the fastest-growing feed consumers, with shrimp alone representing over 180 metric tons of annual demand in Southeast Asia [3]. Red sea bream and ornamental koi farming in Japan also use astaxanthin for pigmentation in the Astaxanthin Market's niche feed verticals.

**Q: How do carbon-credit frameworks apply to microalgae-based astaxanthin production?**
A: Photobioreactor cultivation of Haematococcus pluvialis fixes approximately 1.8 kg of CO₂ per kg of dry biomass, and producers like Algalif Iceland are pursuing voluntary carbon credits under Verra's VCS methodology [19]. This creates a dual-revenue model — natural astaxanthin microalgae source sales plus carbon offsets — that improves project economics for the Astaxanthin Market.

**Q: What IP landscape risks should new entrants to astaxanthin production evaluate?**
A: Over 320 active patent families cover astaxanthin extraction, formulation, and delivery methods globally, with concentrated holdings by AstaReal, BASF, and BGG [23]. New entrants should conduct freedom-to-operate analyses on encapsulation and supercritical CO₂ extraction technologies before committing capital to production in the Astaxanthin Market.


## Sources

[3] Source: FAO, "The State of World Fisheries and Aquaculture 2024," Food and Agriculture Organization, 2024 (fao.org)
[4] Source: Algae Biomass Organization, "Algae Industry Cost Benchmarking Report," ABO, 2024 (algaebiomass.org)
[5] Source: BGG Annual Report 2024, "Yunnan Facility Expansion and Production Metrics," BGG, 2024 (bfrgroup.net)
[6] Source: European Commission, "EU Aquaculture Strategy — Feed Ingredient Standards," EC, 2023 (ec.europa.eu)
[9] Source: Tominaga, K. et al., "Cosmetic Benefits of Astaxanthin on Humans,"  Acta Biochimica Polonica, 2012 (pubmed.ncbi.nlm.nih.gov)
[11] Source: EFSA Panel on Nutrition, "Safety of Astaxanthin from Haematococcus pluvialis,"  EFSA Journal, 2022 (efsa.europa.eu)
[12] Source: Baralic, I. et al., "Effect of Astaxanthin Supplementation on Oxidative Stress,"  Journal of Clinical Biochemistry and Nutrition, 2015 (ncbi.nlm.nih.gov)
[13] Source: SalmonChile, "Chilean Salmon Industry Annual Statistical Report," SalmonChile, 2024 (salmonchile.cl)
[14] Source: Cyanotech Corporation, "BioAstin® Retail Expansion Press Release," Cyanotech, 2024 (cyanotech.com)
[15] Source: U.S. FDA, "GRAS Notices for Astaxanthin-Containing Ingredients," FDA GRAS Database, 2023 (fda.gov)
[16] Source: DSM-Firmenich, "Investor Presentation Q4 2024 — Animal Nutrition Segment," DSM-Firmenich, 2025 (dsm-firmenich.com)
[17] Source: World Bank, "Global Nutrition Report — Emerging Market Supplement Penetration," World Bank, 2024 (worldbank.org)
[19] Source: Algalif Iceland, "Series C Funding Announcement," Algalif, 2024 (algalif.com)
[21] Source: ASC, "ASC Salmon Standard v1.4 — Feed Ingredient Requirements," Aquaculture Stewardship Council, 2023 (asc-aqua.org)
[22] Source: ClinicalTrials.gov, "Registered Astaxanthin Trials," U.S. National Library of Medicine, 2025 (clinicaltrials.gov)

---

*This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/astaxanthin-market-4833*